CONSOLIDATED BALANCE SHEETS (UNAUDITED) (EUR €) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Current Assets
Cash	€ 803	€ 286
Receivable other	39	43
Prepaid expenses	47	52
Total current assets	889	381
Property and equipment, net of accumulated depreciation of E275 at September 30, 2013 and E261 at December 31, 2012	91	28
In-process research and development	2,266	2,266
Goodwill	6,671	6,671
Total assets	9,917	9,346
Current Liabilities
Accounts payable	457	1,325
Deferred revenue	584	1,325
Convertible notes payable to related parties	38,484	34,723
Total current liabilities	39,525	36,048
Acquisition-related contingent consideration	241	6,533
Total liabilities	39,766	42,581
Shareholders' Equity (Deficit)
Common stock, U.S. $.01 par value; nil and 850,000,000 shares authorized at September 30, 2013 and 495,000,000 at December 31, 2012; issued 295,318,813 at September 30, 2013 and at December 31, 2012	2,468	2,468
Additional paid-in capital	33,786	33,783
Deficit accumulated during the development stage	(66,813)	(70,168)
Accumulated other comprehensive income	710	682
Total shareholders' equity (deficit)	(29,849)	(33,235)
Total liabilities and shareholders' equity (deficit)	€ 9,917	€ 9,346